临床儿科杂志 ›› 2019, Vol. 37 ›› Issue (2): 144-.doi: 10.3969/j.issn.1000-3606.2019.02.017

• 文献综述 • 上一篇    下一篇

原发性纤毛不动综合征临床管理的研究进展

魏建华综述 刘恩梅, 谢晓虹, 邓昱审校   

  1. 重庆医科大学附属儿童医院呼吸科 儿童发育疾病研究教育部重点实验室 儿童发育重大疾病国家国 际科技合作基地 儿科学重庆市重点实验室(重庆 400014)
  • 出版日期:2019-02-15 发布日期:2019-02-26

Recent advances of clinical managements of primary ciliary dyskinesia

 Reviewer: WEI Jianhua, Revisor: LIU Enmei, XIE Xiaohong, DENG Yu   

  1. Department of Respiration, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing 400014, China
  • Online:2019-02-15 Published:2019-02-26

摘要: 原发性纤毛不动综合征是一种少见的遗传异质性疾病,虽然其诊断策略逐渐趋于完善,但仍有不少患者因不 能得到有效的临床管理而导致严重后果。文章综述了原发性纤毛不动综合征患者上、下呼吸道及其他系统临床管理的研 究进展,探索统一有效的管理策略。此外,阿奇霉素、基因治疗有望成为其潜在的治疗方法。

关键词: 原发性纤毛不动综合征; 治疗方法; 临床管理; 基因治疗

Abstract: Primary ciliary dyskinesia syndrome (PCD) is a rare genetic disease with high heterogeneity, the diagnostic strategy of PCD is becoming more and more complete. However, the lack of prompt clinical managements for many patients resulted in severe consequences. This article will review on the recent advances of clinical managements of upper and lower respiratory tract and other systems to explore unified and prompt management strategy. In addition, azithromycin and gene editing are promising treatment approaches.

Key words:  primary ciliary dyskinesia; treatment approaches; clinical managements; gene therapy